- Market Realist•13 hours ago
At constant exchange rates, AstraZeneca (AZN) reported an 8% decline in its product sales to ~$21.3 billion during fiscal 2016, as well as a 15% decline in its 4Q16 product sales to ~$5.3 billion.
- Market Realist•15 hours ago
In 4Q16, AstraZeneca (AZN) reported a 12% decline in revenues at constant exchange rates to ~$5.6 billion.
- Market Realist•16 hours ago
AstraZeneca (AZN) reported an ~5% decline in its fiscal 2016 revenues at constant exchange rates. It reported revenues of $23.0 billion, compared to ~$23.6 billion in fiscal 2015.
AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||4,675.00 x 6100|
|Ask||4,675.50 x 13000|
|Day's Range||4,631.00 - 4,732.12|
|52 Week Range||3,680.00 - 5,505.00|
|PE Ratio (TTM)||16.94|
|Dividend & Yield||2.80 (4.82%)|
|1y Target Est||N/A|